Journal of Tropical Medicine

Journal of Tropical Medicine / 2012 / Article
Special Issue

Congenital Transmission by Protozoan

View this Special Issue

Research Article | Open Access

Volume 2012 |Article ID 969243 | 8 pages |

In Vitro Infection of Trypanosoma cruzi Causes Decrease in Glucose Transporter Protein-1 (GLUT1) Expression in Explants of Human Placental Villi Cultured under Normal and High Glucose Concentrations

Academic Editor: Ulrike Kemmerling
Received02 Jun 2011
Accepted15 Jul 2011
Published15 Sep 2011


Trypanosoma cruzi, the etiologic Chagas' disease agent, induces changes in protein pattern of the human placenta syncytiotrophoblast. The glucose transporter protein-1 (GLUT1) is the primary isoform involved in transplacental glucose transport. We carried out in vitro assays to determine if T. cruzi infection would induce changes in placental GLUT1 protein expression under normal and high concentration of glucose. Using Western blot and immunohistological techniques, GLUT1 expression was determined in normal placental villi cultured under normal or high concentrations of glucose, with or without in vitro T. cruzi infection, for 24 and 48 hours. High glucose media or T. cruzi infection alone reduced GLUT1 expression. A yet more accentuated reduction was observed when infection and high glucose condition took place together. We inform, for the first time, that T. cruzi infection may induce reduction of GLUT1 expression under normal and high glucose concentrations, and this effect is synergic to high glucose concentrations.

1. Introduction

Chagas’ disease, endemic in Latin America, is caused by Trypanosoma cruzi a flagellated protozoan with a life cycle involving an insect vector and a mammalian host. The congenital Chagas’ disease is associated with premature labor, miscarriage, and placentitis [1]. In endemic countries, maternal-fetal transmission of T. cruzi is between 1 and 17% of pregnancies in chronically infected mothers, depending on geographic area [2]. The infectious form of the parasite (trypomastigote) adheres to specific receptors on the outer membrane of host cells previous to intracellular invasion [3], and the process of invasion requires activation of signal transduction pathways in the parasite and the host cell [410].

Pancreas is one of the organs affected in Chagas’ Disease. Patients with this disease have plasma pancreatic glucagon and pancreatic polypeptide levels reduced [11], lower insulin activity [12], and morphometric and morphologic alterations of pancreatic ganglia and islets [13]. Experimental infections in hamsters caused pancreatitis, erratic blood glucose levels, and a tendency to hypoinsulinemia [14]. T. cruzi infection-resistant C57BL/6 mice developed high parasitemia and mortality when diabetes was induced with streptozotocin in them [15]. Above clinical and animal studies suggest that patients with Chagas’ Disease are more susceptible to develop hyperglycemia, and this would worsen the infection. In fact, patients with both conditions have been reported, and diabetes or hyperglycemia prevalence was higher in patients with the cardiac form of Chagas’ disease [16].

Hyperglycemia during pregnancy is a well-recognized pathogenic factor. Adequate glucose transfer from the maternal to the fetal compartment is crucial for the normal survival and development of the fetus during pregnancy [17]. GLUT1 is the primary isoform involved in the transplacental movement of glucose and distributed asymmetrically on the microvillus and basal membranes syncytiotrophoblast. The microvillous membrane contains more transporters than the basal. GLUT is inversely regulated by glucose concentration, and basal membrane GLUT1 is positively regulated by insulin-like growth factor I, placental growth hormone, and hypoxia [18]. In vivo, basal membrane GLUT1 is upregulated over gestation, increased in diabetic pregnancy, and decreased in chronic hypoxia, while microvillous membrane GLUT1 is unaffected [18, 19]. As the rate-limiting step in transplacental glucose transport, changes in the density of basal membrane GLUT1 will have a significant impact on transplacental glucose flux [18, 20].

Although increased expression of GLUT1 in placenta from diabetic pregnant women has been reported [18, 20], decrease in GLUT1 mRNA and protein levels in diabetic mice compared with the control and placental cell cultures under high glucose concentration conditions was also informed [20, 21]. Glucose would also alter GLUT1 partitioning between the plasma membrane and intracellular sites in favor of the latter [22].

In the invasion process, T. cruzi has been found to affect numerous surface molecules of the placental villi, probably causing placental dysfunction as consequence. We wondered if this parasite would somehow also affect GLUT1 expression pattern, especially under high glucose (HG) concentration, since T. cruzi has been reported to affect pancreatic function and alters the insulin-glycemia axis, and there is not yet a marker for placental or fetus infection. In this work, we compared the protein expression of GLUT1 of human placental explants infected in vitro with trypomastigotes, cultured under normal and high glucose (HG) concentration.

2. Materials and Methods

2.1. Placentas

Placentas ( 𝑛 = 1 7 ) from clinically and serologically healthy women at 38 to 40 weeks of gestation were obtained by caesarian delivery, in order to assure asepsis. Women signed an informed consent. Placentas were kept in glucose solution 0.29 mM at 4°C for transportation. Once in the laboratory, central villi of placental cotyledons were isolated, rinsed with PBS several times, and cut into pieces of 3 mm in diameter.

2.2. Parasites

Trypomastigotes of T. cruzi (Tulahuen strain) were isolated according to Andrews and Colli [23] and Fretes and Fabro [24], from infected Albino/Swiss mice bloodstream at the peak of parasitism. Briefly, mice blood was centrifuged for 10 minutes at 100 g and kept still for 1 h at 37°C. Plasma was then separated and centrifuged for 10 minutes at 590 g. The pellets containing the parasites were washed twice and suspended in MEM-199 (Gibco Lab., NY, USA).

2.3. Treatments of Placental Explants

Explants of normal human placental villi were cultured at 37°C, in normal atmosphere supplemented with 5% CO2, in MEM-199 (pH 7) with 0.1% penicillin and 0.01% streptomycin and either with 5 mM D-glucose (normal D-glucose: NG) (J.T. Baker, NJ, USA) or 25 mM D-glucose (high glucose: HG) concentrations [22].

After 24 hours, 7 × 105 trypomastigotes Tulahuen strain of T. cruzi were added with the refresh of culture media, prepared as mentioned above. Controls without parasites were carried out for both normal and HG concentrations. Cocultures with trypomastigotes and controls were incubated for another 24 h or 48 h.

After treatment, the placental explants were rinsed with PBS. Part of the explants were fixed with 10% formaldehyde and included in paraffin. Approximately 30 mg of placental explants from each treatment were homogenized in 0.25 mL PBS with an OMNI 1000 homogenizer for five cycles of high speed application, each lasting ten seconds.

2.4. Analysis of Placental Explants Infection

At the end of cultures, placental explants were collected, fixed, and stained with hematoxylin/eosin and PAS/hematoxylin and observed under low and high magnifications in a Zeiss Axioskop 20 microscope. Infection of placental explants was assessed observing amastigote groups of the T. cruzi in trophoblast or stromal cells of the chorionic villi.

2.5. Immunostaining of GLUT1 Protein Expression in Placental Explants

Deparaffinized histological sections were embedded in TBS (pH 7.2), pretreated with 0.05% saponin (15 min) for the unmasking of antigens, then with 3% H2O2 (15 min) to block internal peroxidases, and treated with 3% nonfat dry milk in TBS (15 min) to block nonspecific epitopes. GLUT1 protein was detected by incubating the treated sections with an anti-GLUT1 polyclonal antiserum (rabbit, CHEMICOM International Inc, Temecula, Calif, USA) diluted in TBS/Tween (1 : 500) for overnight, at 4°C, and revealed with a secondary antirabbit immunoglobulin conjugated with peroxidase (Sigma-Aldrich Co, Mo, USA). Peroxidase activity was developed using H2O2/4-Cl-1-naphthol. Background control without addition of anti-GLUT1 antiserum was carried out. We also used precultured placenta controls. Images stored as jpg format were analyzed with “Image Tool” UTHSCSA version 3.00 (downloadable from as described previously [25]. Five optical fields were measured per slide; each treatment for each placenta provided 3 slides. Immunostained area was expressed as ratio of total area (manually selected surface area).

2.6. Western Blot for GLUT1

Homogenized placental villi were mixed with lysis buffer containing protease inhibitors (1% w/v de SDS, 1 mM EDTA, 1 μg/mL of leupeptin, 100 mM of Hepes pH 7.4) and centrifuged at 12000 g for 10 minutes. Protein content was measured with Lowry protein assay [26]. The samples were not heated prior electrophoresis; 40 μg of sample were loaded per lane in a SDS-PAGE gel that was carried out with 3% stacking gel and 10% resolving gel at 200V for 1 hr [27] and blotted onto nitrocellulose at 300 mA for 1.5 hr using a Trans Blot Mini-Protean II apparatus (BioRad, Richmond, Calif, USA). GLUT1 on nitrocellulose was detected with rabbit anti-GLUT1 polyclonal antiserum (CHEMICOM International Inc, Temecula, Calif, USA), diluted 1 : 5000 in TBS-Tween and revealed with a secondary antirabbit immunoglobulin conjugated with peroxidase (Sigma-Aldrich Co, Mo, USA). Peroxidase activity was developed using H2O2/4-Cl-1-naphthol. Background control without addition of anti-GLUT1 antiserum and precultured placenta controls were carried out. Actin was detected as a positive control for protein content present in samples, due the stable expression of this protein.

GLUT1 expression was evaluated with the “Scion image for windows” program (version: Beta 4.0.2) to measure the area units marked by Western blot.

2.7. Statistical Analysis

Data were expressed as the mean ± SE and were analyzed statistically by ANOVA test followed by “post hoc” LSD Fisher test. Paired t-test was performed, to establish significance between groups (different placentas). A level of less than 5% ( 𝑃 < 0 . 0 5 ) was chosen to detect significant differences.

3. Results

Placental explants showed groups of the reproductive forms of the parasite (amastigotes) mainly in stromal cells of the chorionic villi under normal (NG) and high D-glucose (HG) concentrations, as they were seen in placental villi slides stained with PAS/H. Furthermore, the presence of the parasite was more evident when placental explants were cultured with high D-glucose concentration (Figure 1).

Placental villi explants cultured under HG concentration (HGC) underwent structural modifications mainly thickening of the syncytiotrophoblast and basal membranes, increased glycogen deposits, and a fetal capillary thickening, similar to those described in the bibliography [2830]. These alterations were maintained and also were more notorious when these placental explants were infected with T. cruzi, compared to healthy controls incubated with normal glucose concentration (NGC), as shown in placental sections with PAS/H staining (Figure 1).

GLUT1 protein was intensively stained on the apical and basal membrane of the syncytiotrophoblast in controls with NGC and no infection. The apical expression of GLUT1 was scarce under HGC, infection with T. cruzi, or both conditions together, even thought the label increased in basal area under these conditions (Figures 2 and 3).

Image quantification of immunostained areas showed that placental explants cultured under HGC per se reduced the expression of GLUT1 to 34.7% at 24 h (Figure 2) and the level of GLUT1 protein expression recovered to 76.3% at 48 h (Figure 3). In explants invaded by T. cruzi, the expression of GLUT1 protein was reduced under both NG and HG concentrations. At 24 h, the protein expression was reduced to 32% under NGC and to 14.8% under HGC. At 48 h, the GLUT1 protein expression recovered to 37.4% of the initial levels under NGC and to 48.6% under HGC (paired t-test, 𝑃 < 0 . 0 5 ).

Western-blotting image of one of the placental samples as representative of the experiment is shown in Figure 4. Placental explants cultured under HGC per se reduced the expression of GLUT1 to 40.5% at 24 h and the level of GLUT1 protein expression recovered to 56.5% at 48 h. In explants cultured with T. cruzi, the expression of GLUT1 protein was reduced under both NG and HG concentrations. At 24 h, the protein expression was reduced to 59.5% under NGC and to 20% under HGC. At 48 h, the GLUT1 protein expression was at 52.1% and 14.85% of the initial levels, in cultures under NG and HG concentrations, respectively ( 𝑃 < 0 . 0 5 ).

4. Discussion

Different authors have reported that diabetics have an increased susceptibility to a variety of infectious agents [31, 32]. Hyperglycemia has been previously observed to increase the morbidity and mortality of murine T. cruzi infection [15]. Diabetes and hyperglycemia were also reported to be more prevalent in chagasic human patients with the cardiac form of the disease, than in control ones [16]. But, according to the analysis of the bibliography, there is not any study analyzing an association between pregnant women affected with both Chagas’ disease and diabetes with congenital transmission or with the effect on the new born. Furthermore, there is no marker for placental or fetus infection in Chagas’ disease. Due the effect of the Chagas parasite on some proteins located at the lipid raft of chorionic villi trophoblast [24, 33], as well as in trophoblast lipids [34], we aimed to analyze the possible modification of the main glucose transporter located at the syncytiotrophoblast, the GLUT1 protein, produced by placental T. cruzi infection.

T. cruzi crosses the placental barrier and infects the fetus, causing the congenital form of the disease [1]. In order to understand the mechanism used by the parasite to cross this barrier, the interaction between syncytiotrophoblast plasma membranes from the human placenta and the parasite was previously studied, with modifications in lipid and protein patterns from trophoblast membranes being found [35]. However, the mechanism by which the parasite infects the placenta as well as the effects upon the protein contents of the placental barrier is still not well understood.

Our experiments showed that GLUT1 protein expression was significantly diminished in normal placental villi cultured under HGC in vitro infected with T. cruzi, compared to controls, as was observed by GLUT1 immunodetection and western blot. Previous studies have shown that the downregulation of GLUT1 mRNA expression is correlated with decreased glucose uptake in placental trophoblasts cultured under high D-glucose concentration [22]. In the present work, a significant reduction in GLUT1 protein expression was observed in normal placental syncytiotrophoblast, cultured under HGC for either 24 or 48 hours. This corroborates the inverse relation existing between GLUT1 expression and extracellular glucose concentration, as described by various authors [18, 20, 36]. Our results are consistent with previous observations that a reduction in mRNA expression of GLUT1 is induced by a high glucose concentration in cultured placental trophoblast cells [22, 3638].

T. cruzi produces plasmatic membrane modifications, by altering their lipid [34, 35] and protein components, such as placental alkaline phosphatase [79, 3941] and GLUT1 protein, as observed in the present study. On the other hand, we observed in our laboratory, that Gamma-glutamyl transpeptidase, another enzyme present in the placenta’s brush border, is not affected in cells cocultured with T. cruzi [33], suggesting that the parasite affects molecules inserted in lipid microdomains of the membrane, as PLAP [42] and GLUT1 [43]. As the hyperglycemia characteristic of diabetes mellitus also affects these membrane components, we suggest that both the parasite and the high glucose conditions could have been provoking, by different ways, a lower placenta efficacy transporting glucose to fetus. The results obtained in this work demonstrate that placental explants infected with T. cruzi induce changes in GLUT1 expression from human term placenta under high D-glucose concentration. As a consequence, it is of importance to perform a systematic study analyzing new born from pregnant women who have both conditions diabetes and Chagas.

Reduced GLUT1 expression observed in placental culture with parasites could imply a downregulated GLUT1 activity in pregnant women with Chagas’ disease. If this disease is causing damage to pancreas islets [1113], or happens together with a previous diabetic condition, the adverse effects of reduced GLUT1 activity may be exacerbated. The level of GLUT1 is regulated by glucose concentration, insulin-like growth factor I, placental growth hormone, and hypoxia [18]. It would be interesting to further study the mechanisms by which GLUT1 is affected in Chagas’ disease. It is likely that the parasite would perturb other components of the maternal and fetal glucose-insulin-GLUT1 axis. As glucose and GLUT are inversely regulated, changes in GLUT expression might alter the insulin level in plasma, pointing out to determine a marker for placental infection by T. cruzi in pregnant chagasic women. This matter could be of the upmost importance in congenital Chagas’ disease.

Histological studies have demonstrated that placentas from poorly controlled diabetic pregnancies show a thickening of the basal membranes and reduced vascularization of the villi [30]. Similar to observations reported by other authors [28, 29], in the present work we detected that placental villi cultured under high glucose conditions were morphologically altered, with thickening of the basement membranes. The presence of T. cruzi maintains this alteration. The parasite causes disorganization of the basal membrane of the trophoblast and the stroma of the chorionic villi [44], as was observed in in vitro experiments similar to those performed in this work. So, both conditions hyperglycemia and T. cruzi can modify the stroma of the chorionic villi. According to our results, the alteration of the trophoblast basal membrane in the presence of T. cruzi under high D-glucose concentration might be caused by two different mechanisms or not. This important matter should be elucidated.

The protein membrane pattern was also altered, as noted in others works on Placental Alkaline Phosphatase (PLAP) [79, 24, 25, 3941]; and in the present study with GLUT1 protein. These characteristics could modify the human placenta efficacy as a barrier against infections. It has been described that chorionic villi in vitro has low susceptibility to infection by T. cruzi in normal D-glucose concentration [45, 46]. In order to clarify if high D-glucose concentration can increase the infection of chorionic villi by T. cruzi, it is necessary to quantify the infection by T. cruzi of the placental explants under high glucose concentration, in order to analyze the susceptibility of the invasion and the reproduction of the parasite in the placenta, aspect that we are planning to do in further experiments.

With the present work, we report for the first time the effect of T. cruzi on GLUT1 protein expression, adding it to the increasing list of affected proteins altered by this parasite [79, 24, 25, 40, 41].


The authors are thankful to Dr. Patricia Paglini and Dr. Walter Rivarola for providing trypomastigotes of T. cruzi, to Miriam Rabino for technical support, and to Sanatorio Allende and Hospital Nacional de Clínicas de Córdoba for providing human term placentas. This work was supported by grants from Secretaría de Ciencia y Tecnología de la Universidad Nacional de Córdoba, Secretaría de Ciencia y Tecnología de la Universidad Nacional de La Rioja, and MINCyT-Córdoba.


  1. A. L. Bittencourt, “Congenital Chagas disease,” American Journal of Diseases of Children, vol. 130, no. 1, pp. 97–103, 1976. View at: Google Scholar
  2. I. Oliveira, F. Torrico, J. Muñoz, and J. Gascon, “Congenital transmission of Chagas disease: a clinical approach,” Expert Review of Anti-Infective Therapy, vol. 8, no. 8, pp. 945–956, 2010. View at: Publisher Site | Google Scholar
  3. M. Ming, M. Chuenkova, E. Ortega-Barria, and M. E. A. Pereira, “Mediation of Trypanosoma cruzi invasion by sialic acid on the host cell and trans-sialidase on the trypanosome,” Molecular and Biochemical Parasitology, vol. 59, no. 2, pp. 243–252, 1993. View at: Publisher Site | Google Scholar
  4. S. Schenkman, N. W. Andrews, V. Nussenzweig, and E. S. Robbins, “Trypanosoma cruzi invade a mammalian epithelial cell in a polarized manner,” Cell, vol. 55, no. 1, pp. 157–165, 1988. View at: Google Scholar
  5. I. Tardieux, M. H. Nathanson, and N. W. Andrews, “Role in host cell invasion of Trypanosoma cruzi-induced cytosolic-free Ca2+ transients,” Journal of Experimental Medicine, vol. 179, no. 3, pp. 1017–1022, 1994. View at: Google Scholar
  6. A. G. Todorov, M. Einicker-Lamas, S. L. de Castro, M. M. Oliveira, and A. Guilherme, “Activation of host cell phosphatidylinositol 3-kinases by Trypanosoma cruzi infection,” Journal of Biological Chemistry, vol. 275, no. 41, pp. 32182–32186, 2000. View at: Google Scholar
  7. M. J. Sartori, L. Mezzano, S. Lin, S. Muñoz, and S. P. de Fabro, “Role of placental alkaline phosphatase in the internalization of trypomatigotes of Trypanosoma cruzi into HEp2 cells,” Tropical Medicine & International Health, vol. 8, no. 9, pp. 832–839, 2003. View at: Publisher Site | Google Scholar
  8. M. J. Sartori, L. Mezzano, S. Lin, G. Repossi, and S. P. Fabro, “Cellular components and placental alkaline phosphatase in Trypanosoma cruzi infection,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 38, supplement 2, pp. 87–91, 2005. View at: Google Scholar
  9. L. Mezzano, M. J. Sartori, S. Lin, G. Repossi, and S. P. de Fabro, “Placental alkaline phosphatase (PLAP) study in diabetic human placental villi infected with Trypanosoma cruzi,” Placenta, vol. 26, no. 1, pp. 85–92, 2005. View at: Publisher Site | Google Scholar
  10. F. Nagajyothi, L. M. Weiss, D. L. Silver et al., “Trypanosoma cruzi utilizes the host low density lipoprotein receptor in invasion,” PLoS Neglected Tropical Diseases, vol. 5, no. 2, p. e953, 2011. View at: Google Scholar
  11. R. G. Long, R. H. Albuquerque, A. Prata et al., “Response of plasma pancreatic and gastrointestinal hormones and growth hormone to oral and intravenous glucose and insulin hypoglycaemia in Chagas's disease,” Gut, vol. 21, no. 9, pp. 772–777, 1980. View at: Google Scholar
  12. M. E. Guariento, E. Olga, A. Muscelli, and J. A. Gontijo, “Chronotropic and blood pressure response to oral glucose load in Chagas' disease,” Sao Paulo Medical Journal, vol. 112, no. 3, pp. 602–606, 1994. View at: Google Scholar
  13. J. C. Saldanha, V. M. Dos Santos, M. A. Dos Reis, D. F. Da Cunha, and V. P. A. Teixeira, “Morphologic and morphometric evaluation of pancreatic islets in chronic Chagas' disease,” Revista do Hospital das Clinicas de Faculdade de Medicina da Universidade de Sao Paulo, vol. 56, no. 5, pp. 131–138, 2001. View at: Google Scholar
  14. V. M. Dos Santos, M. A. de Lima, M. Cabrine-Santos et al., “Functional and histopathological study of the pancreas in hamsters (Mesocricetus auratus) infected and reinfected with Trypanosoma cruzi,” Parasitology Research, vol. 94, no. 2, pp. 125–133, 2004. View at: Publisher Site | Google Scholar
  15. H. B. Tanowitz, B. Amole, D. Hewlett, and M. Wittner, “Trypanosoma cruzi infection in diabetic mice,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 82, no. 1, pp. 90–93, 1988. View at: Google Scholar
  16. V. M. Dos Santos, S. F. Da Cunha, V. P. Teixeira et al., “Frequency of diabetes mellitus and hyperglycemia in chagasic and non-chagasic women,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 32, no. 5, pp. 489–496, 1999. View at: Google Scholar
  17. H. Li, Y. Gu, Y. Zhang, M. J. Lucas, and Y. Wang, “High glucose levels down-regulate glucose transporter expression that correlates with increased oxidative stress in placental trophoblast cells in vitro,” Journal of the Society for Gynecologic Investigation, vol. 11, no. 2, pp. 75–81, 2004. View at: Publisher Site | Google Scholar
  18. M. U. Baumann, S. Deborde, and N. P. Illsley, “Placental glucose transfer and fetal growth,” Endocrine, vol. 19, no. 1, pp. 13–22, 2002. View at: Publisher Site | Google Scholar
  19. T. Jansson, M. Wennergren, and T. L. Powell, “Placental glucose transport and GLUT 1 expression in insulin-dependent diabetes,” American Journal of Obstetrics and Gynecology, vol. 180, no. 1, part 1, pp. 163–168, 1999. View at: Publisher Site | Google Scholar
  20. N. P. Illsley, “Glucose transporters in the human placenta,” Placenta, vol. 21, no. 1, pp. 14–22, 2000. View at: Publisher Site | Google Scholar
  21. K. Ogura, M. Sakata, M. Yamaguchi, H. Kurachi, and Y. Murata, “High concentration of glucose decreases glucose transporter-1 expression in mouse placenta in vitro and in vivo,” Journal of Endocrinology, vol. 160, no. 3, pp. 443–452, 1999. View at: Google Scholar
  22. T. Hahn, S. Barth, U. Weiss, W. Mosgoeller, and G. Desoye, “Sustained hyperglycemia in vitro down-regulates the GLUT1 glucose transport system of cultured human term placental trophoblast: a mechanism to protect fetal development?” FASEB Journal, vol. 12, no. 12, pp. 1221–1231, 1998. View at: Google Scholar
  23. N. W. Andrews and W. Colli, “Adhesion and interiorization of Trypanosoma cruzi in mammalian cells,” Journal of Protozoology, vol. 29, no. 2, pp. 264–269, 1982. View at: Google Scholar
  24. R. E. Fretes and S. P. de Fabro, “Trypanosoma cruzi: modification of alkaline phosphatase activity induced by trypomastigotes in cultured human placental villi,” Revista do Instituto de Medicina Tropical de Sao Paulo, vol. 32, no. 6, pp. 403–408, 1990. View at: Google Scholar
  25. S. Lin, M. J. Sartori, L. Mezzano, and S. P. de Fabro, “Placental alkaline phosphatase (PLAP) enzyme activity and binding to IgG in Chagas' disease,” Placenta, vol. 26, no. 10, pp. 789–795, 2005. View at: Publisher Site | Google Scholar
  26. O. H. Lowry, N. J. Rosebrough , A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at: Google Scholar
  27. U. K. Laemmli, “Cleavage of structural proteins during the assembly of the head of bacteriophage T4,” Nature, vol. 227, no. 5259, pp. 680–685, 1970. View at: Publisher Site | Google Scholar
  28. P. Vannini, “Pregnancy and diabetes: physiopathological aspects,” Minerva Endocrinologica, vol. 19, no. 2, pp. 45–50, 1994. View at: Google Scholar
  29. P. Garner, “Type I diabetes mellitus and pregnancy,” The Lancet, vol. 346, no. 8968, pp. 157–161, 1995. View at: Google Scholar
  30. G. Desoye and E. Shafrir, “The human placenta in diabetic pregnancy,” Diabetes Reviews, vol. 4, no. 1, pp. 70–89, 1996. View at: Google Scholar
  31. J. F. Plouffe, J. Silva Jr., R. Fekety, and J. L. Allen, “Cell-mediated immunity in diabetes mellitus,” Infection & Immunity, vol. 21, no. 2, pp. 425–429, 1978. View at: Google Scholar
  32. J. Casey and C. Sturm Jr., “Impaired response of lymphocytes from non-insulin-dependent diabetics to staphage lysate and tetanus antigen,” Journal of Clinical Microbiology, vol. 15, no. 1, pp. 109–114, 1982. View at: Google Scholar
  33. S. Priotto, M. J. Sartori, G. Repossi, and M. A. Valentich, “Trypanosoma cruzi: participation of cholesterol and placental alkaline phosphatase in the host cell invasion,” Experimental Parasitology, vol. 122, no. 1, pp. 70–73, 2009. View at: Publisher Site | Google Scholar
  34. A. E. Fabro and G. Calzolari, “Increase of lipids in human chagasic placentas: cytochemical and biochemical study,” Revista de la Facultad de Ciencias Médicas de la Universidad Nacional de Córdoba, vol. 48, no. 1-2, pp. 25–32, 1990. View at: Google Scholar
  35. R. O. Calderón and S. P. de Fabro, “Trypanosoma cruzi: fusogenic ability of membranes from cultured epimastigotes in interaction with human syncytiotrophoblast,” Experimental Parasitology, vol. 56, no. 2, pp. 169–179, 1983. View at: Google Scholar
  36. N. P. Illsley, M. C. Sellers, and R. L. Wright, “Glycaemic regulation of glucose transporter expression and activity in the human placenta,” Placenta, vol. 19, no. 7, pp. 517–524, 1998. View at: Publisher Site | Google Scholar
  37. S. Hauguel-De Mouzon, M. Loizeau, and J. Girard, “Developmental expression of Glut1 glucose transporter and c-fos genes in human placental cells,” Placenta, vol. 15, no. 1, pp. 35–46, 1994. View at: Google Scholar
  38. S. Barth, T. Hahn, R. Zechner, and G. Desoye, “Prolonged hyperglycemia in vitro affects glucose transporter protein Glut 1 and glucose uptake in cultured term trophoblast cells,” Placenta, vol. 15, p. 4A, 1994. View at: Google Scholar
  39. R. E. Fretes and S. P. de Fabro, “Human chagasic placental localization of enzymes associated to syncytiotrophoblast membrane,” Comunicaciones Biolo6gicas, vol. 9, pp. 51–59, 1990. View at: Google Scholar
  40. M. J. Sartori, P. Pons, L. Mezzano, S. Lin, and S. P. de Fabro, “Trypanosoma cruzi infection induces microfilament depletion in human placenta syncytiotrophoblast,” Placenta, vol. 24, no. 7, pp. 767–771, 2003. View at: Publisher Site | Google Scholar
  41. S. Lin, M. J. Sartori, L. Mezzano, and S. P. de Fabro, “Epidermal growth factor (EGF) in the human placental infection with Trypanosoma cruzi,” Placenta, vol. 25, no. 4, pp. 283–286, 2004. View at: Publisher Site | Google Scholar
  42. Z. Salamon, S. Devanathan, I. D. Alves, and G. Tollin, “Plasmon-waveguide resonance studies of lateral segregation of lipids and proteins into microdomains (rafts) in solid-supported bilayers,” Journal of Biological Chemistry, vol. 280, no. 12, pp. 11175–11184, 2005. View at: Publisher Site | Google Scholar
  43. T. Sakyo, H. Naraba, H. Teraoka, and T. Kitagawa, “The intrinsic structure of glucose transporter isoforms Glut1 and Glut3 regulates their differential distribution to detergent-resistant membrane domains in nonpolarized mammalian cells,” FEBS Journal, vol. 274, no. 11, pp. 2843–2853, 2007. View at: Publisher Site | Google Scholar
  44. J. Duaso, G. Rojo, G. Cabrera et al., “Trypanosoma cruzi induces tissue disorganization and destruction of chorionic villi in an ex vivo infection model of human placenta,” Placenta, vol. 31, no. 8, pp. 705–711, 2010. View at: Publisher Site | Google Scholar
  45. C. D. Luján, M. F. Triquell, A. Sembaj, C. E. Guerrero, and R. E. Fretes, “Trypanosoma cruzi: productive infection is not allowed by chorionic villous explant from normal human placenta in vitro,” Experimental Parasitology, vol. 108, no. 3-4, pp. 176–181, 2004. View at: Publisher Site | Google Scholar
  46. M. F. Triquell, C. Díaz-Luján, H. Freilij, P. Paglini, and R. E. Fretes, “Placental infection by two subpopulations of Trypanosoma cruzi is conditioned by differential survival of the parasite in a deleterious placental medium and not by tissue reproduction,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 103, no. 10, pp. 1011–1018, 2009. View at: Publisher Site | Google Scholar

Copyright © 2012 Luciana Mezzano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

999 Views | 595 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.